+226.3%
CLSK vs SPMO
+155.8%
+70.5%
-71.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | SPMO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +6.8% | +0.5% | +6.3% | +5.7% |
| 7D | +7.7% | -0.9% | +8.7% | +9.9% |
| 30D | +12.2% | -1.9% | +14.2% | +17.2% |
| 3M | -15.5% | -1.4% | -14.1% | -14.2% |
| 6M | +39.3% | +25.5% | +13.9% | -14.4% |
| YTD | +35.1% | +24.8% | +10.2% | -15.1% |
| 1Y | +34.0% | +24.5% | +9.5% | -13.0% |
| 3Y | +226.3% | +157.1% | +69.1% | -51.9% |
| All | +226.3% | +155.8% | +70.5% | -51.9% |
Cumulative growth
Daily Returns
Daily percentage return beside SPMO.
Daily Out/Under-Performance
Portfolio return minus SPMO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SPMO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded SPMO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling